W81XWH2220003
Cooperative Agreement
Overview
Grant Description
Prevention of lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells.
Awardee
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Seattle,
Washington
981091024
United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH21BCRPTBCCA
Fred Hutchinson Cancer Center was awarded
Preventing Metastatic Breast Cancer by Eradicating Disseminated Tumor Cells
Cooperative Agreement W81XWH2220003
worth $11,719,011
from Medical Command in August 2022 with work to be completed primarily in Seattle Washington United States.
The grant
has a duration of 4 years and
was awarded through assistance program 12.420 Military Medical Research and Development.
Status
(Ongoing)
Last Modified 8/6/22
Period of Performance
8/1/22
Start Date
7/31/26
End Date
Funding Split
$11.7M
Federal Obligation
$0.0
Non-Federal Obligation
$11.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for W81XWH2220003
Additional Detail
Award ID FAIN
W81XWH2220003
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
TJFZLPP6NYL6
Awardee CAGE
50WB4
Performance District
07
Senators
Maria Cantwell
Patty Murray
Patty Murray
Representative
Pramila Jayapal
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Defense Health Program, Defense (097-0130) | Department of Defense-Military | Grants, subsidies, and contributions (41.0) | $11,719,011 | 100% |
Modified: 8/6/22